Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
Status:
Completed
Trial end date:
2006-04-26
Target enrollment:
Participant gender:
Summary
The study was designed to describe the relationship between dose and pharmacokinetic
parameters of paroxetine over the range of proposed dosage strengths of the paroxetine CR
tablet (12.5 to 37.5 mg) as well as safety profile